Santen Pharmaceutical Co., Ltd. (SNPHF)
OTCMKTS · Delayed Price · Currency is USD
11.45
+0.45 (4.09%)
At close: Jun 11, 2025
Santen Pharmaceutical Market Cap
Santen Pharmaceutical has a market cap or net worth of $3.36 billion as of October 10, 2025. Its market cap has decreased by -23.63% in one year.
Market Cap
3.36B
Enterprise Value
2.80B
Revenue
2.04B
Ranking
n/a
PE Ratio
15.39
Stock Price
$11.45
Market Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 1.19B to 3.36B, an increase of 182.49%. That is a compound annual growth rate of 3.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 3.36B | -4.41% |
| Dec 30, 2024 | 3.52B | -3.14% |
| Dec 29, 2023 | 3.63B | 15.53% |
| Dec 30, 2022 | 3.14B | -35.73% |
| Dec 30, 2021 | 4.89B | -24.57% |
| Dec 30, 2020 | 6.48B | -15.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |